National Advisory Council on Drug Abuse Meeting Notice, May 5, 2026
Summary
The National Institute on Drug Abuse announces a hybrid meeting of the National Advisory Council on Drug Abuse on May 5, 2026, with a closed session from 10:30 a.m. to 12:15 p.m. for grant review and evaluation, and an open session from 1:30 p.m. to 4:30 p.m. for council presentations and business. Interested persons may attend in person at the NIH Neuroscience Building in Rockville, MD, or virtually via NIH Videocast, and may submit written comments to Dr. Gillian Acca.
About this source
GovPing monitors FR: Health and Human Services Department for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 59 changes logged to date.
What changed
NIH published a Federal Register notice announcing a hybrid meeting of the National Advisory Council on Drug Abuse scheduled for May 5, 2026. The meeting includes a closed session from 10:30 a.m. to 12:15 p.m. to review grant applications and an open session from 1:30 p.m. to 4:30 p.m. for council presentations and other business. Affected parties who wish to attend virtually should request accommodations from Dr. Gillian Acca at least ten days in advance, and any interested person may submit written comments via email. The closed portion of the meeting is not open to the public in accordance with statutory provisions governing confidential trade secrets, commercial property, and personal privacy information.
Healthcare researchers, academic institutions, and grant applicants with pending or potential NIDA funding should note this meeting date and the opportunity to submit public comments. Organizations seeking to influence NIDA research priorities or grantmaking direction may use the open session or written-comment pathway to engage with the advisory council.
Meeting
- Date
- 2026-05-05 at 10:30 – 12:15
- Location
- Rockville, MD
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Notice
National Institute on Drug Abuse; Notice of Meeting
A Notice by the National Institutes of Health on 04/24/2026
PDF
Document Details
Document Dates
- Table of Contents
- Public Comments
- Regulations.gov Data
- Sharing
- Other Formats
- Public Inspection Published Document: 2026-08019 (91 FR 22159) Document Headings ###### Department of Health and Human Services
National Institutes of Health
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council on Drug Abuse.
The meeting will be held as a hybrid meeting and is open to the public, as indicated below. Individuals who plan to view the virtual meeting and need special assistance such as sign language interpretation or other reasonable accommodations to view the meeting, should notify Dr. Gillian Acca via email at gillian.acca@nih.gov ten days in advance of the meeting. The open session of the meeting can be accessed from the NIH Videocast at the following link: (http://videocast.nih.gov/).
A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: May 5, 2026.
Closed: 10:30 a.m. to 12:15 p.m.
Agenda: To review and evaluate grant applications.
Open: 1:30 p.m. to 4:30 p.m.
Agenda: Presentations and other business of the Council.
Meeting Format: Hybrid Meeting.
Place: National Institutes of Health, Neuroscience Building, 6001 Executive Boulevard, Room 1135/45/55, Rockville, MD 20852.
Contact Person: Susan R.B. Weiss, Ph.D., Director Division of Extramural Research, Office of the Director, National Institute on Drug Abuse, NIH, Three White Flint North, Rm. 09D08, 11601 Landsdown Street, Bethesda, MD 20852, 301-443-6480, sweiss@nida.nih.gov.
Contact Person: Gillian Acca, Ph.D., Health Scientist Administrator, Division of Extramural Research, Office of Extramural Policy, National Institute on Drug Abuse, NIH, Three White Flint North, Rm. 09C70, 11601 Landsdown Street, Bethesda, MD 20852, 301-827-5863, gillian.acca@nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to Dr. Gillian Acca via email at gillian.acca@nih.gov. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: April 21, 2026.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-08019 Filed 4-23-26; 8:45 am]
BILLING CODE 4167-05-P
Published Document: 2026-08019 (91 FR 22159)
Related changes
Get daily alerts for FR: Health and Human Services Department
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FR: Health and Human Services Department publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.